|Articles|July 22, 2021

WeedMD Rebrands to Entourage Health Corp.

WeedMD, a federally licensed producer and distributor or medical-grade cannabis, will be rebranding as Entourage Health Corp. over the next few months.

WeedMD, a federally licensed producer and distributor or medical-grade cannabis, recently announced in a press release (1), that they will be rebranding as Entourage Health Corp. (Entourage Health) over the next few months.

“This is truly an exciting and transformative time for our Company. WeedMD’s values and principles will always be at the heart of who we are—advocates for our patients, consumers, shareholders, and communities upholding a standard that delivers on quality, sustainability, and experience—now rooted in Entourage Health Corp.,” said George Scorsis, Interim CEO and Executive Chair in the press release (1). “Entourage Health represents WeedMD’s evolution - from its inception in 2013 as one of the first licensed producers, to its launch of award-winning brands, followed by the merger with Starseed Medicinal and pending addition of craft cultivator CannTX—we are a group of professionals who always put the consumer and patient first. We are now looking to develop and expand into new markets and our cannabis experts that make up Entourage Health will expedite and bolster our growth for years to come. I thank our employees, partners and most importantly our shareholders for their unwavering trust and commitment to our success.”

The rebranding was approved at the company’s recent shareholders meeting. In addition, shareholders re-elected the company’s’ board directors: Jason Alexander, Lu Cacioppo, Bruce Croxon, G. Edmund King, Gail Paech, and George Scorsis. The directors will hold office until successors are duly elected or appointed. Furthermore, in accordance with the rules and policies of the TSX Venture Exchange, shareholders re-approved WeedMD’s Omnibus Incentive Plan and re-appointed RSM Canada LLP, as the company’s’ auditor to hold office until the next annual meeting of shareholders or until its successor is appointed.

Additional information regarding the commencement of trading of the company’s common shares on the TSX Venture Exchange under the name Entourage Health Corp will be released at later date.

As WeedMD transitions their business under Entourage Health Corp., its Health Canada license will still continue under its wholly owned subsidiary WeedMD RX Inc.

Reference

  1. https://www.globenewswire.com/en/news-release/2021/07/05/2257655/0/en/WeedMD-Inc-Announces-Intent-to-Change-Corporate-Name-to-Entourage-Health-Corp.html

Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!